Inactive Instrument
Foamix Pharmaceuticals Ltd. Share Price Nasdaq
Stocks
IL0011334385
Biotechnology & Medical Research
| Market Cap | 11Cr 9.48Cr 8.87Cr 8.11Cr 15Cr 1.06TCr 15Cr 104.93Cr 41Cr 531.78Cr 42Cr 41Cr 1.76TCr | P/E 2026 * |
-22.2x | P/E 2027 * | -19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 9.48Cr 8.87Cr 8.11Cr 15Cr 1.06TCr 15Cr 104.93Cr 41Cr 531.78Cr 42Cr 41Cr 1.76TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Foamix Pharmaceuticals Ltd.
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -16.94% | - | - | 1.91Cr | ||
| -4.31% | -2.14% | +65.79% | +103.90% | 7.21TCr | ||
| -4.19% | +1.05% | +52.79% | +85.53% | 6.59TCr | ||
| -3.22% | +23.17% | +1.75% | -5.23% | 2.93TCr | ||
| -1.42% | -3.38% | -5.99% | +465.34% | 2.75TCr | ||
| -4.71% | +5.29% | +47.63% | +8.97% | 2.67TCr | ||
| -1.81% | +0.38% | +34.52% | -18.33% | 2.01TCr | ||
| +5.36% | +4.61% | +270.18% | +415.10% | 1.82TCr | ||
| -2.79% | +0.10% | +12.09% | +549.69% | 1.64TCr | ||
| +0.87% | +4.26% | +41.21% | +150.80% | 1.34TCr | ||
| Average | -1.62% | +8.55% | +57.77% | +195.09% | 3.22TCr | |
| Weighted average by Cap. | -2.83% | +8.78% | +54.39% | +152.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.85Cr -3.3Cr -3.09Cr -2.83Cr -5.33Cr -369.08Cr -5.39Cr -37Cr -14Cr -185.33Cr -14Cr -14Cr -613.19Cr | -6.69Cr -5.73Cr -5.36Cr -4.9Cr -9.25Cr -640.54Cr -9.35Cr -63Cr -25Cr -321.64Cr -25Cr -25Cr -1.06TCr |
| Net Debt | - | - |
Employees
-

















